Panel Recommends Against Approval of Experimental Drug for Alzheimer Disease
FDA panel concluded there is not enough evidence to support the clinical effectiveness of aducanumab
Vitamin D Supplementation May Aid Severe Dermatitis
EASI score significantly lower for pediatric patients receiving vitamin D3 versus placebo with 1 percent hydrocortisone cream
Drug Combo Offers Long-Term Glycemic Control in T2DM
Reduction in HbA1c at 104 weeks greater with exenatide plus dapagliflozin versus either drug alone
Physician’s Briefing Weekly Coronavirus Roundup
Regulators Discuss Approval of New Alzheimer Disease Drug
Aducanumab does not cure or reverse Alzheimer disease; high dose may slow mental decline
AstraZeneca Hopes to Have COVID-19 Vaccine Ready by Year’s End
To ensure the vaccine has the longest possible shelf-life, company is not producing injectable vials of the vaccine yet
$26 Billion Settlement Offer in Opioid Lawsuits Gains Support
According to the general outline of the plan, distributors will pay about $21 billion over 18 years
HPV Vaccine Generally Well Tolerated in Males
Disproportionate reports found for some adverse events, including syncope, with reporting odds ratio of 2.85
Psilocybin Promising for Treating Major Depressive Disorder
Mean GRID Hamilton Depression Rating Scale scores significantly lower in immediate treatment group
CDC: 20.4 Percent of U.S. Adults Had Chronic Pain in 2019
Chronic pain and high-impact chronic pain higher among women, adults ages 65 years and older
